Hypera Pharma
Hypera Pharma previously known as Hypermarcas is the Brazilian largest pharmaceutical company by market capitalization. Its headquarters are located in São Paulo. The company was formerly known as Hypermarcas, before a corporate name change that was announced in December 2017.[2] The official corporate name change is pending approval by the company's Shareholders' Meeting.
 | |
| Type | Sociedade Anônima |
|---|---|
| Ibovespa Component | |
| Industry | Pharmaceuticals |
| Founded | 2001 |
| Headquarters | São Paulo, Brazil |
Key people | Breno Oliveira,(CEO) |
| Products | Drugs Healthcare Cosmetics |
| Revenue |  US$ 1.1 billion (2017)[1] |
 US$ 297.8 million (2017)[1] | |
Number of employees | 7,515 (Dec 31, 2019) |
| Subsidiaries | Mantecorp |
| Website | www.hyperapharma.com.br |
Hypera Pharma's main market segments are Consumer Health, Branded Prescription and Branded Generics.
References
- Terra.com (Portuguese language) Archived 2011-07-06 at the Wayback Machine
- "Hypermarcas quer crescer até 3% acima do mercado em quatro anos". Valor Econômico (in Portuguese). 2017-12-04.
External links
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.